Aug. 9, 2011
/PRNewswire/ -- Stereotaxis, Inc. (NASDAQ: STXS) today announced that executive management will present at the Canaccord Genuity Growth Conference to be held
August 9-11, 2011
at the InterContinental Boston in
Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis, is scheduled to present an overview of the Company on
Thursday, August 11, 2011
1:00 p.m. ET
To listen to the audio web cast of the presentation during or after the event, please visit:
. The replay will be available for ninety days after the event.
Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Niobe® Remote Magnetic Navigation System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure.
Stereotaxis' Odyssey™ portfolio of products provides an innovative enterprise solution for integrating, recording and networking interventional lab information within hospitals and around the world. Odyssey™ Vision integrates data for magnetic and standard interventional labs, enhancing the physician workflow through a consolidated display of multiple systems and eliminating the challenge of interacting simultaneously with many separate diagnostic systems. Odyssey™ Enterprise Cinema then captures a complete record of synchronized procedure data that can be viewed live or from a comprehensive archive of cases performed. Odyssey™ then enables hospitals to efficiently share live and recorded clinical data anywhere around the world to maximize referrals and promote collaboration.